Completion of Innovate UK Grant Project on Personalised Treatment of Oesophageal Cancer

Posted on

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to confirm that is has successfully completed the Innovate UK grant project announced in January 2017.  The project was formally signed off by Innovate UK following a final project meeting in February this year. The Company can confirm that, in line with expectations, it received total funding of £131k from Innovate UK over the course of the project, of which around £81k will be recognised in the Company’s current financial year.

Click here to read in full